MERCOLA – COVID Vaccines Linked to Shingles Reactivation
Multiple studies suggest COVID-19 vaccines may induce persistent shingles reactivation by interfering with the immune system.
Story at a glance:
- According to a recent case study, persistent post-jab shingles were associated with the presence of COVID-19 jab spike protein in the affected skin. The researchers speculate that the COVID-19 jab may induce persistent shingles reactivation by perturbing the immune system.
- Another study details the cases of six patients with autoimmune inflammatory rheumatic diseases who developed shingles shortly after their Pfizer jabs. None of the healthy controls developed shingles post-jab.
- A systematic review also concluded that the COVID-19 jab increases the risk of shingles reactivation if you’ve had it before or have known risk factors for it.
- The COVID-19 shots suppress your innate immune system by inhibiting the type-1 interferon pathway, which is the first-stage response to all viral infections. Type-1 interferon also keeps latent viruses in check, so if your interferon pathway is suppressed, latent viruses can start to emerge.
- Type 1 interferon is suppressed by the jab because it responds to viral RNA, and viral RNA is not present in the COVID-19 shot. The RNA is modified to look like human RNA, so the interferon pathway is not triggered.
According to a recent case study published in the Journal of Cutaneous Immunology and Allergy, persistent post-jab shingles, aka herpes zoster, an infection caused by the varicella-zoster virus, was associated with the presence of COVID-19 jab spike protein in the affected skin.
https://childrenshealthdefense.org/defender/covid-vaccines-shingles-reactivation-cola/?